Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sufentanil vs Remifentanil for Laparoscopic Cholecystectomy Anesthesia
NCT03868111Completed
- Sponsor
- Kangbuk Samsung Hospital
- Start
- Nov 2019
- Primary completion
- Jan 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, triple-blind trial of sufentanil in benign diseases of the gallbladder, sponsored by Kangbuk Samsung Hospital. Primary endpoint: Postoperative wound pain score. Started Nov 2019; status: completed.
02
Drugs
sufentanil
03
Conditions
benign diseases of the gallbladder
Beyond the preview
Go deeper on NCT03868111.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03868111.